Company news
Oramed Pharmaceuticals Inc. news in 2019
Oramed Pharmaceuticals Inc.'s news releases, calls and decks from 2019, newest first.
Oramed Appoints Dr. Arie Mayer to Board of Directors
December 4, 2019
Oramed to Present a Scientific Poster at International Diabetes Federation Congress
December 1, 2019
Oramed Patent Granted in Japan for Protease Inhibitor, a Key Component of Platform Technology
November 20, 2019
Oramed Provides Highlights and Data From Its Phase IIb Oral Insulin Study Investor Event
November 18, 2019
Oramed Pharmaceuticals to Discuss Positive Phase IIb Data at Investor Event and Conference Call on Monday, November 18th
November 13, 2019
Oramed Announces Successful Phase IIb Study of Oral Insulin in Type 2 Diabetes
November 11, 2019
Oramed to Present at Ladenburg Thalmann 2019 Healthcare Conference
September 17, 2019
Oramed Announces Last Patient Treated in Pivotal Phase IIb Trial of Oral Insulin ORMD-0801
September 16, 2019
Oramed to Present at Three Upcoming Conferences
September 2, 2019
Oramed to Present at World Diabetes Congress
July 9, 2019
Oramed Announces Xiaoming Gao Joins Board of Directors
July 1, 2019
Oramed Provides Clinical Update with Meaningful Data Expected by Year-End
June 17, 2019
Oramed to Present at BIO International Convention
June 2, 2019
Oramed to Present at ThinkEquity Conference
April 28, 2019
Oramed to Present at 3rd Annual Clinical Trials Summit
April 10, 2019
Oramed Patent Allowed in the U.S. for Oral Exenatide
April 3, 2019
Oramed to Present at H.C. Wainwright Global Life Sciences Conference
April 2, 2019
Decks in 2019
- Investor Presentation (April 2019)
Investor deck · 44 slides · April 2019